Per Stirling Capital Management’s First Trust Intermediate Duration Investment Grade Corporate ETF FIIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Buy
883,962
+3,637
+0.4% +$75.5K 1.74% 10
2026
Q1
$18.3M Buy
880,325
+137,524
+19% +$2.9M 2.02% 9
2025
Q4
$15.7M Buy
742,801
+26,249
+4% +$558K 1.77% 13
2025
Q3
$15.2M Buy
716,552
+38,690
+6% +$815K 1.82% 13
2025
Q2
$14.2M Buy
677,862
+34,897
+5% +$720K 1.86% 11
2025
Q1
$13.3M Buy
642,965
+8,717
+1% +$179K 1.92% 8
2024
Q4
$13M Buy
634,248
+22,305
+4% +$466K 1.84% 8
2024
Q3
$13.1M Buy
+611,943
New +$12.9M 1.81% 9

Other funds holding FIIG

Per Stirling Capital Management's FIIG Position: Q2 2026 in Review

Per Stirling Capital Management increased its First Trust Intermediate Duration Investment Grade Corporate ETF (FIIG) stake by 0.41% in Q2 2026, buying an estimated $75.5K and bringing the position to 883,962 shares worth $18.3M. The position accounts for 1.74% of the portfolio, ranked #10.

Per Stirling Capital Management first reported a position in FIIG in Q3 2024 and has held it in 8 quarters since. 139 funds tracked by Wall St. Rank hold FIIG as of Q2 2026.

  • Per Stirling Capital Management held 883,962 shares of First Trust Intermediate Duration Investment Grade Corporate ETF worth $18.3M as of Q2 2026.
  • Per Stirling Capital Management bought 3,637 First Trust Intermediate Duration Investment Grade Corporate ETF shares in Q2 2026, an estimated $75.5K.
  • First Trust Intermediate Duration Investment Grade Corporate ETF made up 1.74% of Per Stirling Capital Management's portfolio in Q2 2026, its #10 holding.
  • Per Stirling Capital Management first reported a position in First Trust Intermediate Duration Investment Grade Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • 139 funds tracked by Wall St. Rank held First Trust Intermediate Duration Investment Grade Corporate ETF as of Q2 2026.

Based on Per Stirling Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.